Differences of longitudinal plasma biomarkers between single memory domain and multidomain subjective cognitive decline: Evidence from SILCODE
Journal of Alzheimer’s Disease · 2025
DOI: 10.1177/13872877241309105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Min Wei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Memory. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, STI2030-Major Projects, Sino-German Cooperation Grant.
Abstract (Originalsprache)
Background
Plasma biomarkers demonstrated potential in identifying amyloid pathology in early Alzheimer's disease. Different subtypes of subjective cognitive decline (SCD) may lead to different cognitive impairment conversion risks.
Objective
To investigate the differences of plasma biomarkers in SCD subtypes individuals, which were unclear.
Methods
The 347 individuals were involved, including 93 normal controls (NC), 76 single memory domain SCD (sd-SCD), 79 multidomain SCD (md-SCD), 55 mild cognitive impairment and 44 dementia. We investigated plasma biomarkers (Aβ 42/40 , p-tau181, p-tau217, NfL, and GFAP) and neuropsychological scales in the baseline and follow-up. The Kaplan-Meier survival analysis and Cox proportional hazards model were performed to investigate the risk of cognitive decline conversion. The t-test, Mann-Whitney U and multiple linear regression analysis were employed to evaluate the rate of change and correlation between PET-SUVR and plasma biomarker change.
Results
In cognitively normal subjects, md-SCD exhibited lower Aβ 42/40 and higher p-tau181 and p-tau217 levels. Kaplan-Meier survival analysis revealed that md-SCD group exhibited a higher risk of cognitive decline conversion compared to NC and sd-SCD. Within SCD subgroups, those with positive GFAP status showed higher conversion risk than negative. In the Cox model, the risk of conversion in the md-SCD group was 2.77 times that of sd-SCD. The md-SCD group demonstrated a faster rate of Aβ 42/40 decline than sd-SCD.
Conclusions
The study utilized plasma biomarkers to highlight the significance of staging in SCD. In cognitively normal subjects, md-SCD presents a higher risk of cognitive decline than sd-SCD, providing a valuable reference and convenient tool for early identification of individuals at risk for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
- Institute of Biomedical Engineering, School of Life Sciences, Shanghai University, Shanghai, China.
- State Key Laboratory of Digital Medical Engineering, Key Laboratory of Biomedical Engineering of Hainan Province, School of Biomedical Engineering, Hainan University, Hainan, China.
- Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China.
- National Clinical Research Center for Geriatric Diseases, Beijing, China.
- The Central Hospital of Karamay, Xinjiang, China.
ORCID-Profile: Xianfeng Yu, Shimin Hu, Rong Shi, Ying Zhang, Chenyang Li, Ziyan Song, Jiehui Jiang, Ying Han
Förderung
- National Natural Science Foundation of China
- STI2030-Major Projects
- Sino-German Cooperation Grant
- Shenzhen Bay Scholars Program and Tianchi Scholars Program
Zitieren
APA
Wei, M., Yu, X., Hu, S., Hu, W., Shi, R., Wang, M., Zhong, J., Zhang, Q., Zhang, Y., Li, C., Song, Z., Jiang, J., & Han, Y. (2025). Differences of longitudinal plasma biomarkers between single memory domain and multidomain subjective cognitive decline: Evidence from SILCODE. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877241309105
Vancouver
Wei M, Yu X, Hu S, Hu W, Shi R, Wang M, et al. Differences of longitudinal plasma biomarkers between single memory domain and multidomain subjective cognitive decline: Evidence from SILCODE. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877241309105
BibTeX
@article{Wei2025,
author = {Wei, Min and Yu, Xianfeng and Hu, Shimin and Hu, Wenjing and Shi, Rong and Wang, Min and Zhong, Jiayi and Zhang, Qi and Zhang, Ying and Li, Chenyang and Song, Ziyan and Jiang, Jiehui and Han, Ying},
title = {Differences of longitudinal plasma biomarkers between single memory domain and multidomain subjective cognitive decline: Evidence from SILCODE},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
doi = {10.1177/13872877241309105}
}
EUVIMED